Amrize (NYSE:AMRZ) Hits New 1-Year Low - Should You Sell?

Key Points

• Amrize shares fell to a new 52-week low of $45.84, below their 50-day and 200-day moving averages, after the company missed quarterly EPS estimates by $0.04.
• Analyst sentiment remains generally positive, with a “Moderate Buy” consensus and an average price target of $60.57, although several firms recently cut targets and RBC downgraded the stock to “underperform.”
• The company announced a $0.11 dividend, while insiders bought more than 41,000 shares worth approximately $2.0 million over the past 90 days, potentially signaling confidence despite recent weakness.

Amrize Ltd (NYSE:AMRZ - Get Free Report) shares hit a new 52-week low on Monday . The stock traded as low as $45.84 and last traded at $45.9360, with a volume of 947970 shares changing hands. The stock had previously closed at $46.69.

Analysts Set New Price Targets

AMRZ has been the topic of a number of analyst reports. Royal Bank Of Canada lowered shares of Amrize from a "sector perform" rating to an "underperform" rating and decreased their target price for the stock from $60.00 to $48.00 in a report on Monday, August 10th. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the stock an "overweight" rating in a report on Monday, June 22nd. Stephens decreased their price objective on Amrize from $65.00 to $54.00 and set an "overweight" rating on the stock in a report on Wednesday. Citigroup dropped their target price on Amrize from $66.00 to $58.00 and set a "buy" rating for the company in a research report on Tuesday, August 11th. Finally, Truist Financial reaffirmed a "hold" rating and issued a $48.00 target price (down from $65.00) on shares of Amrize in a research note on Tuesday, July 7th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $60.57.

Amrize Stock Down 1.7%

The stock has a 50 day moving average price of $51.21 and a 200-day moving average price of $54.47. The stock has a market capitalization of $25.38 billion, a P/E ratio of 21.15, a PEG ratio of 1.00 and a beta of 0.12. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The company had revenue of $3.50 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, research analysts expect that Amrize Ltd will post 2.72 EPS for the current fiscal year.

Amrize Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th will be given a $0.11 dividend. The ex-dividend date is Tuesday, August 18th. Amrize's payout ratio is presently 20.28%.

Insider Activity

In other news, insider Stephen S. Clark bought 5,260 shares of the firm's stock in a transaction that occurred on Tuesday, August 11th. The shares were bought at an average cost of $47.31 per share, with a total value of $248,850.60. Following the completion of the purchase, the insider directly owned 10,637 shares in the company, valued at $503,236.47. This represents a 97.82% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, CTO Roald Brouwer purchased 1,500 shares of the stock in a transaction that occurred on Tuesday, August 11th. The shares were purchased at an average price of $46.36 per share, with a total value of $69,540.00. Following the completion of the acquisition, the chief technology officer directly owned 21,490 shares in the company, valued at $996,276.40. The trade was a 7.50% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 41,329 shares of company stock valued at $2,007,181. Corporate insiders own 0.54% of the company's stock.

Institutional Investors Weigh In On Amrize

Several institutional investors and hedge funds have recently bought and sold shares of AMRZ. MCF Advisors LLC bought a new position in shares of Amrize during the fourth quarter valued at approximately $27,000. Basepoint Wealth LLC purchased a new position in Amrize during the 4th quarter valued at $33,000. Laurel Wealth Advisors LLC bought a new position in Amrize in the 4th quarter worth $34,000. Itau Unibanco Holding S.A. raised its holdings in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock worth $41,000 after purchasing an additional 450 shares in the last quarter. Finally, US Bancorp DE purchased a new stake in shares of Amrize in the 3rd quarter worth about $38,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source